Comparative analysis of a flexible novel vaccine platform based on cell permeable chimeric HBV capsids for mucosal vaccination. Raupach J, Housria Y, Hein S, Schnierle B, et al. Vaccine 2025;69:127987.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Raupach J, Housria Y, Hein S, Schnierle B, et al. Comparative analysis of a flexible novel vaccine platform based on cell permeable chimeric HBV capsids for mucosal vaccination. Vaccine 2025;69:127987.
PMID: 41242290